An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Clinical trial NCT00891046 · COMPLETED
Trial details
- NCT number
- NCT00891046
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.